Compare Gartner Inc (IT) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gartner Inc vs Summit Therapeutics Inc — how do they compare? Gartner Inc trades at $186.99 (market cap $11.83B), while Summit Therapeutics Inc trades at $15.6 (market cap $12.06B). The key difference: Gartner Inc and Summit Therapeutics Inc are close in size by market cap, and Gartner Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| IT | SMMT | |
|---|---|---|
Market Cap | $11.83B | $12.06B |
Sector | Technology | Health |
52-Week High | $264.09 | $26.98 |
52-Week Low | $125.68 | $12.55 |
Enterprise Value | $13.57B | $11.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Gartner Inc
Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.
Read more on IT →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
